1. 肺结节病血清生物标志物的研究进展.
- Author
-
余奇龙 and 李长毅
- Abstract
This paper reviewed the research progress of serum biomarkers of pulmonary sarcoidosis in recent years. According to the pathophysiological mechanism, they are classified into monocyte/macrophage related markers, T cell and B cell activation markers, acute phase reaction protein and serum calcium. Currently, angiotensin-converting enzyme (ACE) remains the most widely utilized serum biomarker, while other markers such as cell-free proenzyme activator (CTO), soluble interleukin-2 receptor (sIL-2R), and serum calcium are demonstrating promising clinical applications. Despite certain limitations in the diagnostic use of these serum biomarkers, future research may enhance diagnostic accuracy by developing new biomarkers or investigating combinations of multiple biomarkers, thereby advancing early screening and personalized treatment strategies for pulmonary sarcoidosis. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF